Autogenous vaccine treatment of juvenile laryngeal papillomatosis.
Seventeen cases of juvenile laryngeal papillomatosis have been seen and treated with microlaryngoscopy, removal of papillomas, and administering of autogenous vaccine. Holinger's original findings could be confirmed. The operation frequency of 9 patients was significantly reduced, 5 were improved, and 3 unchanged. In no case was an undesirable reaction to the vaccine observed. Electron microscopy showed no virus-like particles in the papilloma but a section of a vulvar wart did show the virus.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007822:Laryngeal Neoplasms / Q000276:immunology / Q000628:therapy*; D007828:Laryngoscopy; D008297:Male; D008854:Microscopy, Electron; D010212:Papilloma / Q000276:immunology / Q000628:therapy* / Q000648:ultrastructure; D027383:Papillomaviridae / Q000276:immunology*; D053918:Papillomavirus Vaccines; D014765:Viral Vaccines / Q000627:therapeutic use*
D053918:Papillomavirus Vaccines; D014765:Viral Vaccines